Odyssey Therapeutics (ODTX) Net Equity Issued and Repurchased (2023 - 2026)
Odyssey Therapeutics' Net Equity Issued and Repurchased came in at -$3.13 million for Q3 2026, compared with $90.82 million a year earlier.
Odyssey Therapeutics (ODTX) Net Equity Issued and Repurchased (2023 - 2026) Analysis & Trends
Over the trailing twelve months to Sep 30, 2026, Odyssey Therapeutics reported Net Equity Issued and Repurchased of $295.34 million, up 198.7% year-over-year; for FY2025, it came in at $215.57 million, up 670.3% from FY2024.
- Net Equity Issued and Repurchased carries a three-year compound annual growth rate of 6.6% (FY2022 to FY2025).
- Going back by year, Net Equity Issued and Repurchased was $27.99 million in FY2024 (-71.1%), $96.84 million in FY2023 (-45.5%) and $177.84 million in FY2022.
- The Q3 2026 figure represents the lowest quarterly Net Equity Issued and Repurchased in data going back to Q4 2023.
- Business Quant data shows ODTX's Net Equity Issued and Repurchased at $292.06 million (Q2 2026), $651,000 (Q1 2026) and $5.76 million (Q4 2025) in the three quarters before Q3 2026.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Net Equity Issued (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,276.89 Bn | 1,250.50 Bn | 20.46 Bn | -377.00 Mn |
| 2 | Johnson & Johnson | 681.31 Bn | 601.18 Bn | 17.30 Bn | -966.00 Mn |
| 3 | AbbVie | 520.63 Bn | 488.64 Bn | 13.12 Bn | -5.00 Mn |
| 4 | Merck | 357.22 Bn | 320.16 Bn | 13.19 Bn | -406.00 Mn |
| 5 | Novartis Ag | 310.90 Bn | 284.14 Bn | - | - |
| 6 | Astrazeneca | 285.12 Bn | 258.77 Bn | 13.26 Bn | 4.00 Mn |
| 7 | Amgen | 250.23 Bn | 201.89 Bn | 7.58 Bn | - |
| 8 | Gilead Sciences | 207.56 Bn | 182.67 Bn | 6.73 Bn | -283.00 Mn |
| 9 | Pfizer | 164.42 Bn | 111.77 Bn | 12.56 Bn | - |
| 10 | Odyssey Therapeutics | 929.15 Mn | -64.53 Mn | - | -3.13 Mn |
Historic Data
| Date | Value |
|---|---|
| Sep 30, 2026 | -3.13 Mn |
| Jun 30, 2026 | 292.06 Mn |
| Mar 31, 2026 | 651,000.00 |
| Dec 31, 2025 | 5.76 Mn |
| Sep 30, 2025 | 90.82 Mn |
| Jun 30, 2025 | 6,000.00 |
| Mar 31, 2025 | 235,000.00 |
| Dec 31, 2024 | 7.83 Mn |
| Dec 31, 2023 | 26,000.00 |
Odyssey Therapeutics Net Equity Issued and Repurchased API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=net-equity-issued-and-repurchased&ticker=ODTX&period=max&api_key=YOUR_API_KEY
import requests
url = "https://data.businessquant.com/historic"
params = {"slug": "net-equity-issued-and-repurchased", "ticker": "ODTX", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()
const res = await fetch("https://data.businessquant.com/historic?slug=net-equity-issued-and-repurchased&ticker=ODTX&period=max&api_key=YOUR_API_KEY");
const data = await res.json();